Cargando…
A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient
ERBB4 fusion is a rare, novel oncogenic event involved in the development of lung adenocarcinoma that is not routinely looked for, although ERBB4 fusion is a potential target for existing pan-ErbB tyrosine kinase and must be implemented in the laboratory https://bit.ly/3nYmGQ9
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005686/ https://www.ncbi.nlm.nih.gov/pubmed/33816604 http://dx.doi.org/10.1183/23120541.00582-2020 |
_version_ | 1783672162583838720 |
---|---|
author | Guenzi, Edouard Pluvy, Johan Guyard, Alice Nguenang, Marina Rebah, Khedidja Benrahmoune, Zoubida Lamoril, Jérome Cazes, Aurelie Gounant, Valérie Brosseau, Solenn Boileau, Catherine Zalcman, Gérard Théou-Anton, Nathalie |
author_facet | Guenzi, Edouard Pluvy, Johan Guyard, Alice Nguenang, Marina Rebah, Khedidja Benrahmoune, Zoubida Lamoril, Jérome Cazes, Aurelie Gounant, Valérie Brosseau, Solenn Boileau, Catherine Zalcman, Gérard Théou-Anton, Nathalie |
author_sort | Guenzi, Edouard |
collection | PubMed |
description | ERBB4 fusion is a rare, novel oncogenic event involved in the development of lung adenocarcinoma that is not routinely looked for, although ERBB4 fusion is a potential target for existing pan-ErbB tyrosine kinase and must be implemented in the laboratory https://bit.ly/3nYmGQ9 |
format | Online Article Text |
id | pubmed-8005686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-80056862021-04-02 A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient Guenzi, Edouard Pluvy, Johan Guyard, Alice Nguenang, Marina Rebah, Khedidja Benrahmoune, Zoubida Lamoril, Jérome Cazes, Aurelie Gounant, Valérie Brosseau, Solenn Boileau, Catherine Zalcman, Gérard Théou-Anton, Nathalie ERJ Open Res Original Research Letters ERBB4 fusion is a rare, novel oncogenic event involved in the development of lung adenocarcinoma that is not routinely looked for, although ERBB4 fusion is a potential target for existing pan-ErbB tyrosine kinase and must be implemented in the laboratory https://bit.ly/3nYmGQ9 European Respiratory Society 2021-03-29 /pmc/articles/PMC8005686/ /pubmed/33816604 http://dx.doi.org/10.1183/23120541.00582-2020 Text en Copyright ©The authors 2021 http://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Original Research Letters Guenzi, Edouard Pluvy, Johan Guyard, Alice Nguenang, Marina Rebah, Khedidja Benrahmoune, Zoubida Lamoril, Jérome Cazes, Aurelie Gounant, Valérie Brosseau, Solenn Boileau, Catherine Zalcman, Gérard Théou-Anton, Nathalie A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient |
title | A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient |
title_full | A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient |
title_fullStr | A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient |
title_full_unstemmed | A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient |
title_short | A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient |
title_sort | new kif5b–erbb4 gene fusion in a lung adenocarcinoma patient |
topic | Original Research Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005686/ https://www.ncbi.nlm.nih.gov/pubmed/33816604 http://dx.doi.org/10.1183/23120541.00582-2020 |
work_keys_str_mv | AT guenziedouard anewkif5berbb4genefusioninalungadenocarcinomapatient AT pluvyjohan anewkif5berbb4genefusioninalungadenocarcinomapatient AT guyardalice anewkif5berbb4genefusioninalungadenocarcinomapatient AT nguenangmarina anewkif5berbb4genefusioninalungadenocarcinomapatient AT rebahkhedidja anewkif5berbb4genefusioninalungadenocarcinomapatient AT benrahmounezoubida anewkif5berbb4genefusioninalungadenocarcinomapatient AT lamoriljerome anewkif5berbb4genefusioninalungadenocarcinomapatient AT cazesaurelie anewkif5berbb4genefusioninalungadenocarcinomapatient AT gounantvalerie anewkif5berbb4genefusioninalungadenocarcinomapatient AT brosseausolenn anewkif5berbb4genefusioninalungadenocarcinomapatient AT boileaucatherine anewkif5berbb4genefusioninalungadenocarcinomapatient AT zalcmangerard anewkif5berbb4genefusioninalungadenocarcinomapatient AT theouantonnathalie anewkif5berbb4genefusioninalungadenocarcinomapatient AT guenziedouard newkif5berbb4genefusioninalungadenocarcinomapatient AT pluvyjohan newkif5berbb4genefusioninalungadenocarcinomapatient AT guyardalice newkif5berbb4genefusioninalungadenocarcinomapatient AT nguenangmarina newkif5berbb4genefusioninalungadenocarcinomapatient AT rebahkhedidja newkif5berbb4genefusioninalungadenocarcinomapatient AT benrahmounezoubida newkif5berbb4genefusioninalungadenocarcinomapatient AT lamoriljerome newkif5berbb4genefusioninalungadenocarcinomapatient AT cazesaurelie newkif5berbb4genefusioninalungadenocarcinomapatient AT gounantvalerie newkif5berbb4genefusioninalungadenocarcinomapatient AT brosseausolenn newkif5berbb4genefusioninalungadenocarcinomapatient AT boileaucatherine newkif5berbb4genefusioninalungadenocarcinomapatient AT zalcmangerard newkif5berbb4genefusioninalungadenocarcinomapatient AT theouantonnathalie newkif5berbb4genefusioninalungadenocarcinomapatient |